Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma

17 Jul 2026
Views: 0
0

Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma

Orrapin S, Sirikaew N, Chiangjong W, Chutipongtanate S, Teeyakasem P, Udomruk S, Moonmuang S, Sutthitthasakul S, Yongpitakwattana P, Phanphaisarn A, Suksakit P, Pasena A, Kamngoen R, Svasti J, Champattanachai V, Settakorn J, Pruksakorn D, Chaiyawat P*

Cancer Cell Int. 2026. doi: 10.1186/s12935-026-04386-0.

Tags

Share this

Related Posts

Spatial proximity of Tumor-Immune interactions predicts patient outcome in hepatocellular carcinoma. Maestri E, Kedei N, Khatib S, Forgues M, Ylaya K, Hewitt SM, Wang L, Chaisaingmongkol J, Ruchirawat M, Ma L, Wang XW. Hepatology. 2023. (In press)
16 Oct 2023
Views: 0

Spatial proximity of Tumor-Immune interactions predicts patient outcome in hepatocellular carcinoma. Maestri E, Kedei N, Khatib S, Forgues M, Ylaya K, Hewitt SM, Wang L, Chaisaingmongkol J, Ruchirawat M, Ma L, Wang XW. Hepatology. 2023. (In press)

Spatial proximity of Tumor-Immune interactions predicts patient outcome in hepatocellular carcinoma. Maestri E, Kedei N, Khatib S, Forgues M, Ylaya K, Hewitt SM, Wang L, Chaisaingmongkol J, Ruchirawat M, Ma L, Wang XW. Hepatology. 2023. (In press)
View More

Recent Posts